Tag:
shingles
Latest Headlines
Latest Headlines
Shingles shot safe and well-tolerated, study finds
Shingles can lead to post-herpetic pain and other issues in older people, and the vaccine, which halves the chance of severe attacks of shingles, is safe and well-tolerated in this group, a new study finds.
Study: No benefit for Merck's zoster booster
A paper presented to the American Academy of Dermatology looked at the effectiveness of a booster shot of a VZV vaccine.
Shingles vaccination levels fall short of expectations
Five years ago, Merck gained FDA approval for its shingles prevention vaccine Zostavax. The agency recently expanded that approval to adults 50 years and older. Yet vaccination rates remain low due
FDA approves Merck's Zostavax for more adults
Three months after the CDC recommended all adults over the age of 60 receive Merck's Zostavax vaccine, the FDA has approved the shingles preventative for use in adults ages 50 to 59. The FDA approved
Virus present up to one month after Zostavax immunization
Some patients inoculated with Zostavax, Merck's shingles vaccine, shed the virus used for the vaccine through their saliva for one month after immunization, according to a researcher from the
Merck's Zostavax halves risk of shingles
Although shingles isn't cureable, a retrospective study has found that Merck's Zostavax vaccine can cut a person's risk of of developing the illness by 55 percent. It is the only shingles vax
Inhibitex shares crater as lead drug flunks Ph2
Shares of Inhibitex ( $INHX ) slid 25 percent on the news that its lead drug for shingles failed a mid-stage trial. Investigators recruited 350 patients to test two doses of FV-100 against GSK's
Chickenpox vax program a success
Reports of chickenpox have drastically declined as a result of the national vaccination program implemented in the 1990s. In a study published in the journal Pediatrics today, CDC researchers report
